Post-exposure prophylaxis
194 results
1 - 100
Post-exposure prophylaxis- DEFINITION
- INDICATIONS
- CLINICAL RECOMMENDATION
- Efficacy and Duration of PEP (Post-Exposure Prophylaxis)
- Selection of PEP Agents
- Drugs for PEP
- Monitoring and Counseling: All
- Adjunctive Treatment, Monitoring, and Counseling: oPEP
- Adjunctive Treatment, Monitoring and Counseling: HCW
- Adjunctive Treatment, Monitoring and Counseling: nPEP
- Hepatitis B Post-Exposure Prophylaxis
- Hepatitis C Occupational Exposure
- Useful Management Resources
- OTHER INFORMATION
- Basis for recommendation
- References
Anthrax, Pre-exposure and Post-Exposure Prevention- GamaSTAN
- Anthrax vaccine
- Anthrax vaccine
- Hep B-Hyperimmune globulin
- Dolutegravir
- Dolutegravir
- Rabies vaccines
- Francisella tularensis
- Emtricitabine
- Emtricitabine
- Macacine herpesvirus 1
- Syphilis
- Tetanus Immune Globulin
- Hepatitis B (HBV) vaccines
- Hepatitis B (HBV) vaccines
- Rabies- Hyper immune globulin
- Bite Wounds
- Intravenous immune globulin
- Intravenous immune globulin
- Varicella Zoster- Hyperimmune globulin
- Pemgarda (pemivibart)
- HIV, Occupational Exposure
- HIV, Occupational Exposure
- Hepatitis A vaccine (HAV)
- Hepatitis A vaccine (HAV)
Human Immunodeficiency Virus (HIV)- Penicillin
- Ciprofloxacin
- Ciprofloxacin
- Neisseria gonorrhoeae
- Pre-exposure Prophylaxis
- Trichinella species
- Hepatitis A
- Anthrax
- Zanamivir
- Tick-borne encephalitis virus
- Nevirapine
- Nevirapine
- Molnupiravir
- Borrelia species
- Treponema pallidum (syphilis)
- Molnupiravir
- Coronavirus COVID-19 (SARS-CoV-2)
- Coronavirus COVID-19 (SARS-CoV-2)
- Hepatitis C
- Burkholderia pseudomallei (Meloidosis)
- Lamivudine